No clinically meaningful differences were recorded in the overall incidence of local and systemic adverse events between patients in the vaccine and placebo groups ; 68 ( 86 % ) of 79 participants in the vaccine groups had solicited systemic adverse events compared with 13 ( 76 % ) of 17 of those in the placebo groups .